| Dr Thomas W Stone, MD | |
|
6450 Dutchmans Pkwy, Louisville, KY 40205-3338 | |
| (859) 263-3900 | |
| Not Available |
| Full Name | Dr Thomas W Stone |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 29 Years |
| Location | 6450 Dutchmans Pkwy, Louisville, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528064219 | NPI | - | NPPES |
| 1811027000 | Medicaid | WV | |
| 64045701 | Medicaid | KY | |
| 2318370 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 37096 (Kentucky) | Secondary |
| 207WX0107X | Ophthalmology - Retina Specialist | 37096 (Kentucky) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Retina And Vitreous Associates Of Kentucky Pllc | 0749183648 | 14 |
| Retina And Vitreous Associates Of Kentucky Pllc | 0749183648 | 14 |
News Archive
Dentists need to take a closer look at potential hazards of exposing patients to zinc, a common ingredient of many dental products, according to a report by Amar Patel, DDS, resident and colleagues at the University of Maryland Dental School in the March/April 2011 issue of the journal General Dentistry.
Recently, a group of researchers analyzed 122 pregnant women and their neonates at the time of birth. All the women studied received 1 or both doses of a messenger RNA (mRNA)-based vaccine for COVID-19. Of the 122 women part of the study, 55 had received only the first dose of the vaccine while 67 women had received both doses of the mRNA vaccine by the time they gave birth; 85 women had received the Pfizer-BioNTech vaccine, and 37 women received the Moderna vaccine. The study is published on the preprint server, bioRxiv.
"African Americans are less likely than whites to survive breast, prostate and ovarian cancer even when they receive equal treatment, according to a large study that offers provocative evidence that biological factors play a role in at least some racial disparities," the Washington Post reports.
Mitotech S.A, a Luxembourg-based clinical-stage biotechnology company developing novel antioxidant molecules targeting mitochondria, today announced that it has achieved significant positive results in its U.S. Phase II clinical trial of SkQ1 compound in patients with moderate to severe dry eye syndrome.
The U.S. Food and Drug Administration has approved Somatuline Depot (lanreotide acetate injection) for the treatment of acromegaly, a rare and potentially life threatening disease in adults caused by abnormal secretion of growth hormone (GH), commonly from a benign tumor located in the pituitary gland located in the brain.
› Verified 8 days ago
| Entity Name | Retina And Vitreous Associates Of Kentucky Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619949971 PECOS PAC ID: 0749183648 Enrollment ID: O20040128001145 |
News Archive
Dentists need to take a closer look at potential hazards of exposing patients to zinc, a common ingredient of many dental products, according to a report by Amar Patel, DDS, resident and colleagues at the University of Maryland Dental School in the March/April 2011 issue of the journal General Dentistry.
Recently, a group of researchers analyzed 122 pregnant women and their neonates at the time of birth. All the women studied received 1 or both doses of a messenger RNA (mRNA)-based vaccine for COVID-19. Of the 122 women part of the study, 55 had received only the first dose of the vaccine while 67 women had received both doses of the mRNA vaccine by the time they gave birth; 85 women had received the Pfizer-BioNTech vaccine, and 37 women received the Moderna vaccine. The study is published on the preprint server, bioRxiv.
"African Americans are less likely than whites to survive breast, prostate and ovarian cancer even when they receive equal treatment, according to a large study that offers provocative evidence that biological factors play a role in at least some racial disparities," the Washington Post reports.
Mitotech S.A, a Luxembourg-based clinical-stage biotechnology company developing novel antioxidant molecules targeting mitochondria, today announced that it has achieved significant positive results in its U.S. Phase II clinical trial of SkQ1 compound in patients with moderate to severe dry eye syndrome.
The U.S. Food and Drug Administration has approved Somatuline Depot (lanreotide acetate injection) for the treatment of acromegaly, a rare and potentially life threatening disease in adults caused by abnormal secretion of growth hormone (GH), commonly from a benign tumor located in the pituitary gland located in the brain.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas W Stone, MD 120 N Eagle Creek Dr, Ste 500, Lexington, KY 40509-1827 Ph: (859) 263-3900 | Dr Thomas W Stone, MD 6450 Dutchmans Pkwy, Louisville, KY 40205-3338 Ph: (859) 263-3900 |
News Archive
Dentists need to take a closer look at potential hazards of exposing patients to zinc, a common ingredient of many dental products, according to a report by Amar Patel, DDS, resident and colleagues at the University of Maryland Dental School in the March/April 2011 issue of the journal General Dentistry.
Recently, a group of researchers analyzed 122 pregnant women and their neonates at the time of birth. All the women studied received 1 or both doses of a messenger RNA (mRNA)-based vaccine for COVID-19. Of the 122 women part of the study, 55 had received only the first dose of the vaccine while 67 women had received both doses of the mRNA vaccine by the time they gave birth; 85 women had received the Pfizer-BioNTech vaccine, and 37 women received the Moderna vaccine. The study is published on the preprint server, bioRxiv.
"African Americans are less likely than whites to survive breast, prostate and ovarian cancer even when they receive equal treatment, according to a large study that offers provocative evidence that biological factors play a role in at least some racial disparities," the Washington Post reports.
Mitotech S.A, a Luxembourg-based clinical-stage biotechnology company developing novel antioxidant molecules targeting mitochondria, today announced that it has achieved significant positive results in its U.S. Phase II clinical trial of SkQ1 compound in patients with moderate to severe dry eye syndrome.
The U.S. Food and Drug Administration has approved Somatuline Depot (lanreotide acetate injection) for the treatment of acromegaly, a rare and potentially life threatening disease in adults caused by abnormal secretion of growth hormone (GH), commonly from a benign tumor located in the pituitary gland located in the brain.
› Verified 8 days ago
Dr. Brennan P Greene, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1536 Story Ave, The Eye Care Institute Building, Louisville, KY 40206 Phone: 502-589-1500 Fax: 502-589-1556 | |
Theodore M Wandzilak, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 1348 Poplar Level Rd, Louisville, KY 40217 Phone: 502-634-8100 Fax: 502-637-6396 | |
Donald Walter Bennett, OD MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1935 Bluegrass Ave, Suite 200, Louisville, KY 40215 Phone: 502-895-0040 Fax: 502-361-4488 | |
Dr. Mark Cassol, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 800 Zorn Ave, Louisville, KY 40206 Phone: 502-287-4000 | |
Lawrence Tenkman, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1935 Bluegrass Ave, Suite 200, Louisville, KY 40215 Phone: 502-895-0040 Fax: 502-361-4488 | |
Dr. Jacob Jones Yunker, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3810 Springhurst Blvd, Suite 100, Louisville, KY 40241 Phone: 502-897-9881 Fax: 502-897-9824 | |
Christopher J Compton, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 301 E Muhammad Ali Blvd, Louisville, KY 40202 Phone: 502-852-1665 |